HEPION PHARMACEUTICALS, INC. Class of Warrant or Right, Outstanding
HEPION PHARMACEUTICALS, INC. (HEPA) had Class of Warrant or Right, Outstanding of 3.48 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2026-06-30: Class of Warrant or Right, Outstanding 3.48M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 3.48M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 3.48M shares.
- 2022-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 3.48M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 3.48M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 3.48M shares 10-Q · filed 2026-08-13 |
| 2022-12-31 | 0.00 shares 10-K · filed 2023-04-10 |
| 2021-12-31 | 10.71K shares 10-K · filed 2023-04-10 |
| 2020-12-31 | 102.64K shares 10-K · filed 2023-04-10 |
| 2019-12-31 | 108.00K shares 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |